内分泌系検査世界市場の発展状況と動向 2024-2030
英文タイトル: Global Endocrine Testing Market Insights, Forecast to 2030
販売価格(消費税別)
個人版
マルチユーザー版
企業版
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。
※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。
概要
本報告書は内分泌系検査市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは内分泌系検査の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。
世界の内分泌系検査市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは内分泌系検査のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に内分泌系検査市場を分類しています。本研究に含まれる主な企業は:Abbott Laboratories、AdnaGen、Beckman Coulter/Danaher、Biomedical Diagnostics、BioMerieux、Bio-Rad、Dako、DiaSorin、Eiken、Fujirebio、Instrumentation Laboratory、Kyowa Medex、Matritech、Ortho-Clinical Diagnostics、Roche、Siemens、Sysmex、Thermo Fisher、Tosoh、Wako、Wallac/PE
地域別市場区分、地域別分析は以下の通り:
アメリカとカナダ
中国
アジア
ヨーロッパ
中東、アフリカ、ラテンアメリカ
タイプ別市場セグメント:
Tandem Mass Spectrometry
Immunoassay
用途別の市場セグメント:
Hospitals
Commercial Laboratories
Ambulatory Care Centres
Other Setting
本レポートの詳細内容
世界の内分泌系検査市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、内分泌系検査タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の内分泌系検査収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の内分泌系検査市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、内分泌系検査市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。
内分泌系検査のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。
章の概要
第1章:内分泌系検査のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント(製品タイプ、用途など)のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。(2019~2030)
第2章:内分泌系検査の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。(2019~2030)
第3章内分泌系検査企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。(2019~2030)
第4章:各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(2019~2024)
第5章:内分泌系検査の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。(2019~2030)
第6章:北米(米国、カナダ)のタイプ別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第7章:ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第8章:中国の種類別、および用途別、各セグメントの収益。(2019~2030)
第9章アジア(中国を除く)の種類別、用途別、地域別、セグメントごとの収益。(2019~2030)
第10章:中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第11章:内分泌系検査の主要企業の概要を提供し、製品の説明と仕様、内分泌系検査の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。(2019~2024)
第12章:アナリストの見解/結論
概要
The endocrine system is an integrated network that consists of various glands located throughout the body. Market Analysis and Insights: Global Endocrine Testing Market The global Endocrine Testing market is projected to grow from US$ 8408.2 million in 2024 to US$ 12270 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period. Growing incidences of endocrine disorders such as hyperthyroidism and adrenal insufficiency is predicted to boost the demand for endocrine testing. Report Covers: This report presents an overview of global market for Endocrine Testing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. This report researches the key producers of Endocrine Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Endocrine Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries. This report focuses on the Endocrine Testing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Endocrine Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Endocrine Testing revenue, projected growth trends, production technology, application and end-user industry. Descriptive company profiles of the major global players, including Abbott Laboratories, AdnaGen, Beckman Coulter/Danaher, Biomedical Diagnostics, BioMerieux, Bio-Rad, Dako, DiaSorin and Eiken, etc. Market Segmentation By Company Abbott Laboratories AdnaGen Beckman Coulter/Danaher Biomedical Diagnostics BioMerieux Bio-Rad Dako DiaSorin Eiken Fujirebio Instrumentation Laboratory Kyowa Medex Matritech Ortho-Clinical Diagnostics Roche Siemens Sysmex Thermo Fisher Tosoh Wako Wallac/PE Segment by Type Tandem Mass Spectrometry Immunoassay Segment by Application Hospitals Commercial Laboratories Ambulatory Care Centres Other Setting By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe China Asia (excluding China) Japan South Korea China Taiwan Southeast Asia India Latin America, Middle East & Africa Brazil Mexico Turkey Israel GCC Countries Chapter Outline Chapter Outline Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 2: Revenue of Endocrine Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 3: Detailed analysis of Endocrine Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment. Chapter 7: Europe by Type, by Application and by country, revenue for each segment. Chapter 8: China by Type, and by Application, revenue for each segment. Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment. Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment. Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Endocrine Testing revenue, gross margin, and recent development, etc. Chapter 12: Analyst's Viewpoints/Conclusions
総目録
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endocrine Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Tandem Mass Spectrometry
1.2.3 Immunoassay
1.3 Market by Application
1.3.1 Global Endocrine Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Commercial Laboratories
1.3.4 Ambulatory Care Centres
1.3.5 Other Setting
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Endocrine Testing Market Perspective (2019-2030)
2.2 Global Endocrine Testing Growth Trends by Region
2.2.1 Endocrine Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Endocrine Testing Historic Market Size by Region (2019-2024)
2.2.3 Endocrine Testing Forecasted Market Size by Region (2025-2030)
2.3 Endocrine Testing Market Dynamics
2.3.1 Endocrine Testing Industry Trends
2.3.2 Endocrine Testing Market Drivers
2.3.3 Endocrine Testing Market Challenges
2.3.4 Endocrine Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Endocrine Testing by Players
3.1.1 Global Endocrine Testing Revenue by Players (2019-2024)
3.1.2 Global Endocrine Testing Revenue Market Share by Players (2019-2024)
3.2 Global Endocrine Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Endocrine Testing, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Endocrine Testing Market Concentration Ratio
3.4.1 Global Endocrine Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endocrine Testing Revenue in 2023
3.5 Global Key Players of Endocrine Testing Head office and Area Served
3.6 Global Key Players of Endocrine Testing, Product and Application
3.7 Global Key Players of Endocrine Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Endocrine Testing Breakdown Data by Type
4.1 Global Endocrine Testing Historic Market Size by Type (2019-2024)
4.2 Global Endocrine Testing Forecasted Market Size by Type (2025-2030)
5 Endocrine Testing Breakdown Data by Application
5.1 Global Endocrine Testing Historic Market Size by Application (2019-2024)
5.2 Global Endocrine Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Endocrine Testing Market Size (2019-2030)
6.2 North America Endocrine Testing Market Size by Type
6.2.1 North America Endocrine Testing Market Size by Type (2019-2024)
6.2.2 North America Endocrine Testing Market Size by Type (2025-2030)
6.2.3 North America Endocrine Testing Market Share by Type (2019-2030)
6.3 North America Endocrine Testing Market Size by Application
6.3.1 North America Endocrine Testing Market Size by Application (2019-2024)
6.3.2 North America Endocrine Testing Market Size by Application (2025-2030)
6.3.3 North America Endocrine Testing Market Share by Application (2019-2030)
6.4 North America Endocrine Testing Market Size by Country
6.4.1 North America Endocrine Testing Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Endocrine Testing Market Size by Country (2019-2024)
6.4.3 North America Endocrine Testing Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Endocrine Testing Market Size (2019-2030)
7.2 Europe Endocrine Testing Market Size by Type
7.2.1 Europe Endocrine Testing Market Size by Type (2019-2024)
7.2.2 Europe Endocrine Testing Market Size by Type (2025-2030)
7.2.3 Europe Endocrine Testing Market Share by Type (2019-2030)
7.3 Europe Endocrine Testing Market Size by Application
7.3.1 Europe Endocrine Testing Market Size by Application (2019-2024)
7.3.2 Europe Endocrine Testing Market Size by Application (2025-2030)
7.3.3 Europe Endocrine Testing Market Share by Application (2019-2030)
7.4 Europe Endocrine Testing Market Size by Country
7.4.1 Europe Endocrine Testing Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Endocrine Testing Market Size by Country (2019-2024)
7.4.3 Europe Endocrine Testing Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Endocrine Testing Market Size (2019-2030)
8.2 China Endocrine Testing Market Size by Type
8.2.1 China Endocrine Testing Market Size by Type (2019-2024)
8.2.2 China Endocrine Testing Market Size by Type (2025-2030)
8.2.3 China Endocrine Testing Market Share by Type (2019-2030)
8.3 China Endocrine Testing Market Size by Application
8.3.1 China Endocrine Testing Market Size by Application (2019-2024)
8.3.2 China Endocrine Testing Market Size by Application (2025-2030)
8.3.3 China Endocrine Testing Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Endocrine Testing Market Size (2019-2030)
9.2 Asia Endocrine Testing Market Size by Type
9.2.1 Asia Endocrine Testing Market Size by Type (2019-2024)
9.2.2 Asia Endocrine Testing Market Size by Type (2025-2030)
9.2.3 Asia Endocrine Testing Market Share by Type (2019-2030)
9.3 Asia Endocrine Testing Market Size by Application
9.3.1 Asia Endocrine Testing Market Size by Application (2019-2024)
9.3.2 Asia Endocrine Testing Market Size by Application (2025-2030)
9.3.3 Asia Endocrine Testing Market Share by Application (2019-2030)
9.4 Asia Endocrine Testing Market Size by Region
9.4.1 Asia Endocrine Testing Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Endocrine Testing Market Size by Region (2019-2024)
9.4.3 Asia Endocrine Testing Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Endocrine Testing Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Endocrine Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Endocrine Testing Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Endocrine Testing Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Endocrine Testing Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Endocrine Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Endocrine Testing Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Endocrine Testing Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Endocrine Testing Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Endocrine Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Endocrine Testing Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Endocrine Testing Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Endocrine Testing Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Endocrine Testing Introduction
11.1.4 Abbott Laboratories Revenue in Endocrine Testing Business (2019-2024)
11.1.5 Abbott Laboratories Recent Developments
11.2 AdnaGen
11.2.1 AdnaGen Company Details
11.2.2 AdnaGen Business Overview
11.2.3 AdnaGen Endocrine Testing Introduction
11.2.4 AdnaGen Revenue in Endocrine Testing Business (2019-2024)
11.2.5 AdnaGen Recent Developments
11.3 Beckman Coulter/Danaher
11.3.1 Beckman Coulter/Danaher Company Details
11.3.2 Beckman Coulter/Danaher Business Overview
11.3.3 Beckman Coulter/Danaher Endocrine Testing Introduction
11.3.4 Beckman Coulter/Danaher Revenue in Endocrine Testing Business (2019-2024)
11.3.5 Beckman Coulter/Danaher Recent Developments
11.4 Biomedical Diagnostics
11.4.1 Biomedical Diagnostics Company Details
11.4.2 Biomedical Diagnostics Business Overview
11.4.3 Biomedical Diagnostics Endocrine Testing Introduction
11.4.4 Biomedical Diagnostics Revenue in Endocrine Testing Business (2019-2024)
11.4.5 Biomedical Diagnostics Recent Developments
11.5 BioMerieux
11.5.1 BioMerieux Company Details
11.5.2 BioMerieux Business Overview
11.5.3 BioMerieux Endocrine Testing Introduction
11.5.4 BioMerieux Revenue in Endocrine Testing Business (2019-2024)
11.5.5 BioMerieux Recent Developments
11.6 Bio-Rad
11.6.1 Bio-Rad Company Details
11.6.2 Bio-Rad Business Overview
11.6.3 Bio-Rad Endocrine Testing Introduction
11.6.4 Bio-Rad Revenue in Endocrine Testing Business (2019-2024)
11.6.5 Bio-Rad Recent Developments
11.7 Dako
11.7.1 Dako Company Details
11.7.2 Dako Business Overview
11.7.3 Dako Endocrine Testing Introduction
11.7.4 Dako Revenue in Endocrine Testing Business (2019-2024)
11.7.5 Dako Recent Developments
11.8 DiaSorin
11.8.1 DiaSorin Company Details
11.8.2 DiaSorin Business Overview
11.8.3 DiaSorin Endocrine Testing Introduction
11.8.4 DiaSorin Revenue in Endocrine Testing Business (2019-2024)
11.8.5 DiaSorin Recent Developments
11.9 Eiken
11.9.1 Eiken Company Details
11.9.2 Eiken Business Overview
11.9.3 Eiken Endocrine Testing Introduction
11.9.4 Eiken Revenue in Endocrine Testing Business (2019-2024)
11.9.5 Eiken Recent Developments
11.10 Fujirebio
11.10.1 Fujirebio Company Details
11.10.2 Fujirebio Business Overview
11.10.3 Fujirebio Endocrine Testing Introduction
11.10.4 Fujirebio Revenue in Endocrine Testing Business (2019-2024)
11.10.5 Fujirebio Recent Developments
11.11 Instrumentation Laboratory
11.11.1 Instrumentation Laboratory Company Details
11.11.2 Instrumentation Laboratory Business Overview
11.11.3 Instrumentation Laboratory Endocrine Testing Introduction
11.11.4 Instrumentation Laboratory Revenue in Endocrine Testing Business (2019-2024)
11.11.5 Instrumentation Laboratory Recent Developments
11.12 Kyowa Medex
11.12.1 Kyowa Medex Company Details
11.12.2 Kyowa Medex Business Overview
11.12.3 Kyowa Medex Endocrine Testing Introduction
11.12.4 Kyowa Medex Revenue in Endocrine Testing Business (2019-2024)
11.12.5 Kyowa Medex Recent Developments
11.13 Matritech
11.13.1 Matritech Company Details
11.13.2 Matritech Business Overview
11.13.3 Matritech Endocrine Testing Introduction
11.13.4 Matritech Revenue in Endocrine Testing Business (2019-2024)
11.13.5 Matritech Recent Developments
11.14 Ortho-Clinical Diagnostics
11.14.1 Ortho-Clinical Diagnostics Company Details
11.14.2 Ortho-Clinical Diagnostics Business Overview
11.14.3 Ortho-Clinical Diagnostics Endocrine Testing Introduction
11.14.4 Ortho-Clinical Diagnostics Revenue in Endocrine Testing Business (2019-2024)
11.14.5 Ortho-Clinical Diagnostics Recent Developments
11.15 Roche
11.15.1 Roche Company Details
11.15.2 Roche Business Overview
11.15.3 Roche Endocrine Testing Introduction
11.15.4 Roche Revenue in Endocrine Testing Business (2019-2024)
11.15.5 Roche Recent Developments
11.16 Siemens
11.16.1 Siemens Company Details
11.16.2 Siemens Business Overview
11.16.3 Siemens Endocrine Testing Introduction
11.16.4 Siemens Revenue in Endocrine Testing Business (2019-2024)
11.16.5 Siemens Recent Developments
11.17 Sysmex
11.17.1 Sysmex Company Details
11.17.2 Sysmex Business Overview
11.17.3 Sysmex Endocrine Testing Introduction
11.17.4 Sysmex Revenue in Endocrine Testing Business (2019-2024)
11.17.5 Sysmex Recent Developments
11.18 Thermo Fisher
11.18.1 Thermo Fisher Company Details
11.18.2 Thermo Fisher Business Overview
11.18.3 Thermo Fisher Endocrine Testing Introduction
11.18.4 Thermo Fisher Revenue in Endocrine Testing Business (2019-2024)
11.18.5 Thermo Fisher Recent Developments
11.19 Tosoh
11.19.1 Tosoh Company Details
11.19.2 Tosoh Business Overview
11.19.3 Tosoh Endocrine Testing Introduction
11.19.4 Tosoh Revenue in Endocrine Testing Business (2019-2024)
11.19.5 Tosoh Recent Developments
11.20 Wako
11.20.1 Wako Company Details
11.20.2 Wako Business Overview
11.20.3 Wako Endocrine Testing Introduction
11.20.4 Wako Revenue in Endocrine Testing Business (2019-2024)
11.20.5 Wako Recent Developments
11.21 Wallac/PE
11.21.1 Wallac/PE Company Details
11.21.2 Wallac/PE Business Overview
11.21.3 Wallac/PE Endocrine Testing Introduction
11.21.4 Wallac/PE Revenue in Endocrine Testing Business (2019-2024)
11.21.5 Wallac/PE Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
表と図のリスト
List of Tables Table 1. Global Endocrine Testing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030 Table 2. Key Players of Tandem Mass Spectrometry Table 3. Key Players of Immunoassay Table 4. Global Endocrine Testing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030 Table 5. Global Endocrine Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 6. Global Endocrine Testing Market Size by Region (2019-2024) & (US$ Million) Table 7. Global Endocrine Testing Market Share by Region (2019-2024) Table 8. Global Endocrine Testing Forecasted Market Size by Region (2025-2030) & (US$ Million) Table 9. Global Endocrine Testing Market Share by Region (2025-2030) Table 10. Endocrine Testing Market Trends Table 11. Endocrine Testing Market Drivers Table 12. Endocrine Testing Market Challenges Table 13. Endocrine Testing Market Restraints Table 14. Global Endocrine Testing Revenue by Players (2019-2024) & (US$ Million) Table 15. Global Endocrine Testing Revenue Share by Players (2019-2024) Table 16. Global Top Endocrine Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocrine Testing as of 2023) Table 17. Global Endocrine Testing Industry Ranking 2022 VS 2023 VS 2024 Table 18. Global 5 Largest Players Market Share by Endocrine Testing Revenue (CR5 and HHI) & (2019-2024) Table 19. Global Key Players of Endocrine Testing, Headquarters and Area Served Table 20. Global Key Players of Endocrine Testing, Product and Application Table 21. Global Key Players of Endocrine Testing, Product and Application Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Endocrine Testing Market Size by Type (2019-2024) & (US$ Million) Table 24. Global Endocrine Testing Revenue Market Share by Type (2019-2024) Table 25. Global Endocrine Testing Forecasted Market Size by Type (2025-2030) & (US$ Million) Table 26. Global Endocrine Testing Revenue Market Share by Type (2025-2030) Table 27. Global Endocrine Testing Market Size by Application (2019-2024) & (US$ Million) Table 28. Global Endocrine Testing Revenue Share by Application (2019-2024) Table 29. Global Endocrine Testing Forecasted Market Size by Application (2025-2030) & (US$ Million) Table 30. Global Endocrine Testing Revenue Share by Application (2025-2030) Table 31. North America Endocrine Testing Market Size by Type (2019-2024) & (US$ Million) Table 32. North America Endocrine Testing Market Size by Type (2025-2030) & (US$ Million) Table 33. North America Endocrine Testing Market Size by Application (2019-2024) & (US$ Million) Table 34. North America Endocrine Testing Market Size by Application (2025-2030) & (US$ Million) Table 35. North America Endocrine Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 36. North America Endocrine Testing Market Size by Country (2019-2024) & (US$ Million) Table 37. North America Endocrine Testing Market Size by Country (2025-2030) & (US$ Million) Table 38. Europe Endocrine Testing Market Size by Type (2019-2024) & (US$ Million) Table 39. Europe Endocrine Testing Market Size by Type (2025-2030) & (US$ Million) Table 40. Europe Endocrine Testing Market Size by Application (2019-2024) & (US$ Million) Table 41. Europe Endocrine Testing Market Size by Application (2025-2030) & (US$ Million) Table 42. Europe Endocrine Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 43. Europe Endocrine Testing Market Size by Country (2019-2024) & (US$ Million) Table 44. Europe Endocrine Testing Market Size by Country (2025-2030) & (US$ Million) Table 45. China Endocrine Testing Market Size by Type (2019-2024) & (US$ Million) Table 46. China Endocrine Testing Market Size by Type (2025-2030) & (US$ Million) Table 47. China Endocrine Testing Market Size by Application (2019-2024) & (US$ Million) Table 48. China Endocrine Testing Market Size by Application (2025-2030) & (US$ Million) Table 49. Asia Endocrine Testing Market Size by Type (2019-2024) & (US$ Million) Table 50. Asia Endocrine Testing Market Size by Type (2025-2030) & (US$ Million) Table 51. Asia Endocrine Testing Market Size by Application (2019-2024) & (US$ Million) Table 52. Asia Endocrine Testing Market Size by Application (2025-2030) & (US$ Million) Table 53. Asia Endocrine Testing Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 54. Asia Endocrine Testing Market Size by Region (2019-2024) & (US$ Million) Table 55. Asia Endocrine Testing Market Size by Region (2025-2030) & (US$ Million) Table 56. Middle East, Africa, and Latin America Endocrine Testing Market Size by Type (2019-2024) & (US$ Million) Table 57. Middle East, Africa, and Latin America Endocrine Testing Market Size by Type (2025-2030) & (US$ Million) Table 58. Middle East, Africa, and Latin America Endocrine Testing Market Size by Application (2019-2024) & (US$ Million) Table 59. Middle East, Africa, and Latin America Endocrine Testing Market Size by Application (2025-2030) & (US$ Million) Table 60. Middle East, Africa, and Latin America Endocrine Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 61. Middle East, Africa, and Latin America Endocrine Testing Market Size by Country (2019-2024) & (US$ Million) Table 62. Middle East, Africa, and Latin America Endocrine Testing Market Size by Country (2025-2030) & (US$ Million) Table 63. Abbott Laboratories Company Details Table 64. Abbott Laboratories Business Overview Table 65. Abbott Laboratories Endocrine Testing Product Table 66. Abbott Laboratories Revenue in Endocrine Testing Business (2019-2024) & (US$ Million) Table 67. Abbott Laboratories Recent Developments Table 68. AdnaGen Company Details Table 69. AdnaGen Business Overview Table 70. AdnaGen Endocrine Testing Product Table 71. AdnaGen Revenue in Endocrine Testing Business (2019-2024) & (US$ Million) Table 72. AdnaGen Recent Developments Table 73. Beckman Coulter/Danaher Company Details Table 74. Beckman Coulter/Danaher Business Overview Table 75. Beckman Coulter/Danaher Endocrine Testing Product Table 76. Beckman Coulter/Danaher Revenue in Endocrine Testing Business (2019-2024) & (US$ Million) Table 77. Beckman Coulter/Danaher Recent Developments Table 78. Biomedical Diagnostics Company Details Table 79. Biomedical Diagnostics Business Overview Table 80. Biomedical Diagnostics Endocrine Testing Product Table 81. Biomedical Diagnostics Revenue in Endocrine Testing Business (2019-2024) & (US$ Million) Table 82. Biomedical Diagnostics Recent Developments Table 83. BioMerieux Company Details Table 84. BioMerieux Business Overview Table 85. BioMerieux Endocrine Testing Product Table 86. BioMerieux Revenue in Endocrine Testing Business (2019-2024) & (US$ Million) Table 87. BioMerieux Recent Developments Table 88. Bio-Rad Company Details Table 89. Bio-Rad Business Overview Table 90. Bio-Rad Endocrine Testing Product Table 91. Bio-Rad Revenue in Endocrine Testing Business (2019-2024) & (US$ Million) Table 92. Bio-Rad Recent Developments Table 93. Dako Company Details Table 94. Dako Business Overview Table 95. Dako Endocrine Testing Product Table 96. Dako Revenue in Endocrine Testing Business (2019-2024) & (US$ Million) Table 97. Dako Recent Developments Table 98. DiaSorin Company Details Table 99. DiaSorin Business Overview Table 100. DiaSorin Endocrine Testing Product Table 101. DiaSorin Revenue in Endocrine Testing Business (2019-2024) & (US$ Million) Table 102. DiaSorin Recent Developments Table 103. Eiken Company Details Table 104. Eiken Business Overview Table 105. Eiken Endocrine Testing Product Table 106. Eiken Revenue in Endocrine Testing Business (2019-2024) & (US$ Million) Table 107. Eiken Recent Developments Table 108. Fujirebio Company Details Table 109. Fujirebio Business Overview Table 110. Fujirebio Endocrine Testing Product Table 111. Fujirebio Revenue in Endocrine Testing Business (2019-2024) & (US$ Million) Table 112. Fujirebio Recent Developments Table 113. Instrumentation Laboratory Company Details Table 114. Instrumentation Laboratory Business Overview Table 115. Instrumentation Laboratory Endocrine Testing Product Table 116. Instrumentation Laboratory Revenue in Endocrine Testing Business (2019-2024) & (US$ Million) Table 117. Instrumentation Laboratory Recent Developments Table 118. Kyowa Medex Company Details Table 119. Kyowa Medex Business Overview Table 120. Kyowa Medex Endocrine Testing Product Table 121. Kyowa Medex Revenue in Endocrine Testing Business (2019-2024) & (US$ Million) Table 122. Kyowa Medex Recent Developments Table 123. Matritech Company Details Table 124. Matritech Business Overview Table 125. Matritech Endocrine Testing Product Table 126. Matritech Revenue in Endocrine Testing Business (2019-2024) & (US$ Million) Table 127. Matritech Recent Developments Table 128. Ortho-Clinical Diagnostics Company Details Table 129. Ortho-Clinical Diagnostics Business Overview Table 130. Ortho-Clinical Diagnostics Endocrine Testing Product Table 131. Ortho-Clinical Diagnostics Revenue in Endocrine Testing Business (2019-2024) & (US$ Million) Table 132. Ortho-Clinical Diagnostics Recent Developments Table 133. Roche Company Details Table 134. Roche Business Overview Table 135. Roche Endocrine Testing Product Table 136. Roche Revenue in Endocrine Testing Business (2019-2024) & (US$ Million) Table 137. Roche Recent Developments Table 138. Siemens Company Details Table 139. Siemens Business Overview Table 140. Siemens Endocrine Testing Product Table 141. Siemens Revenue in Endocrine Testing Business (2019-2024) & (US$ Million) Table 142. Siemens Recent Developments Table 143. Sysmex Company Details Table 144. Sysmex Business Overview Table 145. Sysmex Endocrine Testing Product Table 146. Sysmex Revenue in Endocrine Testing Business (2019-2024) & (US$ Million) Table 147. Sysmex Recent Developments Table 148. Thermo Fisher Company Details Table 149. Thermo Fisher Business Overview Table 150. Thermo Fisher Endocrine Testing Product Table 151. Thermo Fisher Revenue in Endocrine Testing Business (2019-2024) & (US$ Million) Table 152. Thermo Fisher Recent Developments Table 153. Tosoh Company Details Table 154. Tosoh Business Overview Table 155. Tosoh Endocrine Testing Product Table 156. Tosoh Revenue in Endocrine Testing Business (2019-2024) & (US$ Million) Table 157. Tosoh Recent Developments Table 158. Wako Company Details Table 159. Wako Business Overview Table 160. Wako Endocrine Testing Product Table 161. Wako Revenue in Endocrine Testing Business (2019-2024) & (US$ Million) Table 162. Wako Recent Developments Table 163. Wallac/PE Company Details Table 164. Wallac/PE Business Overview Table 165. Wallac/PE Endocrine Testing Product Table 166. Wallac/PE Revenue in Endocrine Testing Business (2019-2024) & (US$ Million) Table 167. Wallac/PE Recent Developments Table 168. Research Programs/Design for This Report Table 169. Key Data Information from Secondary Sources Table 170. Key Data Information from Primary Sources List of Figures Figure 1. Global Endocrine Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million) Figure 2. Global Endocrine Testing Market Share by Type: 2023 VS 2030 Figure 3. Tandem Mass Spectrometry Features Figure 4. Immunoassay Features Figure 5. Global Endocrine Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million) Figure 6. Global Endocrine Testing Market Share by Application: 2023 VS 2030 Figure 7. Hospitals Case Studies Figure 8. Commercial Laboratories Case Studies Figure 9. Ambulatory Care Centres Case Studies Figure 10. Other Setting Case Studies Figure 11. Endocrine Testing Report Years Considered Figure 12. Global Endocrine Testing Market Size (US$ Million), Year-over-Year: 2019-2030 Figure 13. Global Endocrine Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030 Figure 14. Global Endocrine Testing Market Share by Region: 2023 VS 2030 Figure 15. Global Endocrine Testing Market Share by Players in 2023 Figure 16. Global Top Endocrine Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocrine Testing as of 2023) Figure 17. The Top 10 and 5 Players Market Share by Endocrine Testing Revenue in 2023 Figure 18. North America Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million) Figure 19. North America Endocrine Testing Market Share by Type (2019-2030) Figure 20. North America Endocrine Testing Market Share by Application (2019-2030) Figure 21. North America Endocrine Testing Market Share by Country (2019-2030) Figure 22. United States Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million) Figure 23. Canada Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million) Figure 24. Europe Endocrine Testing Market Size YoY (2019-2030) & (US$ Million) Figure 25. Europe Endocrine Testing Market Share by Type (2019-2030) Figure 26. Europe Endocrine Testing Market Share by Application (2019-2030) Figure 27. Europe Endocrine Testing Market Share by Country (2019-2030) Figure 28. Germany Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million) Figure 29. France Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million) Figure 30. U.K. Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million) Figure 31. Italy Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million) Figure 32. Russia Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million) Figure 33. Nordic Countries Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million) Figure 34. China Endocrine Testing Market Size YoY (2019-2030) & (US$ Million) Figure 35. China Endocrine Testing Market Share by Type (2019-2030) Figure 36. China Endocrine Testing Market Share by Application (2019-2030) Figure 37. Asia Endocrine Testing Market Size YoY (2019-2030) & (US$ Million) Figure 38. Asia Endocrine Testing Market Share by Type (2019-2030) Figure 39. Asia Endocrine Testing Market Share by Application (2019-2030) Figure 40. Asia Endocrine Testing Market Share by Region (2019-2030) Figure 41. Japan Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million) Figure 42. South Korea Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million) Figure 43. China Taiwan Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million) Figure 44. Southeast Asia Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million) Figure 45. India Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million) Figure 46. Australia Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million) Figure 47. Middle East, Africa, and Latin America Endocrine Testing Market Size YoY (2019-2030) & (US$ Million) Figure 48. Middle East, Africa, and Latin America Endocrine Testing Market Share by Type (2019-2030) Figure 49. Middle East, Africa, and Latin America Endocrine Testing Market Share by Application (2019-2030) Figure 50. Middle East, Africa, and Latin America Endocrine Testing Market Share by Country (2019-2030) Figure 51. Brazil Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million) Figure 52. Mexico Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million) Figure 53. Turkey Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million) Figure 54. Saudi Arabia Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million) Figure 55. Israel Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million) Figure 56. GCC Countries Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million) Figure 57. Abbott Laboratories Revenue Growth Rate in Endocrine Testing Business (2019-2024) Figure 58. AdnaGen Revenue Growth Rate in Endocrine Testing Business (2019-2024) Figure 59. Beckman Coulter/Danaher Revenue Growth Rate in Endocrine Testing Business (2019-2024) Figure 60. Biomedical Diagnostics Revenue Growth Rate in Endocrine Testing Business (2019-2024) Figure 61. BioMerieux Revenue Growth Rate in Endocrine Testing Business (2019-2024) Figure 62. Bio-Rad Revenue Growth Rate in Endocrine Testing Business (2019-2024) Figure 63. Dako Revenue Growth Rate in Endocrine Testing Business (2019-2024) Figure 64. DiaSorin Revenue Growth Rate in Endocrine Testing Business (2019-2024) Figure 65. Eiken Revenue Growth Rate in Endocrine Testing Business (2019-2024) Figure 66. Fujirebio Revenue Growth Rate in Endocrine Testing Business (2019-2024) Figure 67. Instrumentation Laboratory Revenue Growth Rate in Endocrine Testing Business (2019-2024) Figure 68. Kyowa Medex Revenue Growth Rate in Endocrine Testing Business (2019-2024) Figure 69. Matritech Revenue Growth Rate in Endocrine Testing Business (2019-2024) Figure 70. Ortho-Clinical Diagnostics Revenue Growth Rate in Endocrine Testing Business (2019-2024) Figure 71. Roche Revenue Growth Rate in Endocrine Testing Business (2019-2024) Figure 72. Siemens Revenue Growth Rate in Endocrine Testing Business (2019-2024) Figure 73. Sysmex Revenue Growth Rate in Endocrine Testing Business (2019-2024) Figure 74. Thermo Fisher Revenue Growth Rate in Endocrine Testing Business (2019-2024) Figure 75. Tosoh Revenue Growth Rate in Endocrine Testing Business (2019-2024) Figure 76. Wako Revenue Growth Rate in Endocrine Testing Business (2019-2024) Figure 77. Wallac/PE Revenue Growth Rate in Endocrine Testing Business (2019-2024) Figure 78. Bottom-up and Top-down Approaches for This Report Figure 79. Data Triangulation Figure 80. Key Executives Interviewed
01. サンプル提供
ご購入前にサンプル(英語、日本語)が提供可能。
02. カスタマイズサービス
レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。
03. プロフェッショナルな日本語翻訳
AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。
04. 多言語コミュニケーション
日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。
05. お支払方法
銀行振込(納品後、ご請求書送付)。
06. アフターサービス
ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。
請求書払いの場合:
レポート選択
見積もり依頼
メールでのご注文
入手(英語版は2〜4営業日、日本語版は8〜10営業日)
決済(後払い)
クレジットカード決済の場合:
レポート選択
ウェブサイトでのご注文
決済
入手(英語版は2〜4営業日、日本語版は8〜10営業日)